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INTRODUCTION
The ischemic process and reperfusion trigger different
pathophysiological events, among them reduced adenosine
triphosphate production, loss of ion pump homeostasis,
increased intracellular calcium, formation of free radicals,
inflammatory response, leukocyte activation, membrane
depolarization with an excessive release of excitatory amino
acids such as glutamate and dopamine, and induction of
apoptosis (Hachimini-Idrissi et al., 2004).
N-methyl-D-aspartate (NMDA) receptors is a type
of ionotrophic Ca2+  receptor gated channel and is extensively
distributed in the central nervous system (CNS). NMDAR
(NMDA receptor) subunit is coded by two gene families:
NMDAR1 and NMDAR2; NMDAR1 subunit is rigueur to
form the NMDAR (Luo et al., 1997). In the mammalian
CNS, NMDAR serves prominent roles the pathophysiologic
process of ischemia becoming over excited during cerebral
ischemia to induce Ca2+ influx and exacerbate neural injury
(Monaghan et al., 1989; Collingridge & Singer, 1990).
Glutamate is the major excitatory neurotransmitter
in the brain of mammals and a key mediator of intracellular
communication, plasticity, growth and differentiation. The
glutamate participates in ischemic neuronal injury
stimulating the receptors of the calcium channels mainly the
NMDA-type, allowing exaggerated penetration of
intracellular calcium, which triggers the cascade of events
that culminate with the enzyme cell death (theory of toxicity
excitatory) (Lipton & Rosenberg, 1994; Pulsinelli, 1995).
Several pharmacological procedures have been used
in an attempt to reduce the area involved in the ischemic
process. Among them, hypothermia (Baker et al., 1995; Li
et al., 2005), and anti-inflammatory drugs (Asanuma et al.,
1997; Dietrich et al., 1999; Dias et al., 1999)  and
hypothermia in combination with anti-inflammatory drugs
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SUMMARY: NMDAR (N-methyl-D-aspartate receptor) is one subtype of ionotrophic glutamate receptor which is extensively
distributed in the central nervous system (CNS). In the mammalian CNS, NMDAR serves prominent roles in the pathophysiologic
process of cerebral ischemia. This study aimed to investigate the pattern of expression of protein and gene of the excitatory neurotransmitter
NMDAR in experimental focal cerebral ischemia and the hole of neuroprotection with hypothermia and ketoprofen. 120 rats were
randomly divided into 6 groups (20 animals each): control - no surgery; sham - simulation of surgery; ischemic - focal ischemia for 1
hour, without reperfusion; ischemic + intraischemic hypothermia; ischemic + previous intravenous ketoprofen, and ischemic + hypothermia
and ketoprofen. Ten animals from each experimental group were used to establish the volume of infarct. Transient focal cerebral ischemia
was obtained in rats by occlusion of the middle cerebral artery with an intraluminal suture. The infarct volume was measured using
morphometric analysis of infarct areas defined by triphenyl tetrazolium chloride and the patterns of expression of the protein and gene
NMDA were evaluated by immunohistochemistry and quantitative real-time PCR, respectively. Increases in the protein and gene NMDA
receptor in the ischemics areas were observed and these increases were reduced by hypothermia and ketoprofen. The increase in the
NMDA receptor protein and gene expression observed in the ischemic animals was reduced by neuroprotection (hypothermia and
ketoprofen). The NMDA receptor increases in the ischemic area suggests that the NMDA mediated neuroexcitotoxicity plays an important
role in cell death and that the neuroprotective effect of both, hypothermia and ketoprofen is directly involved with the NMDA.
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(Dietrich et al.), has proved to be effective in providing
protection after cerebral ischemia. Anti-inflammatory agents
are used to attenuate the inflammatory response triggered
by the ischemic phenomenon (Dietrich et al.), with emphasis
on ketoprofen (Asanuma et al.; Dias et al.), a non steroid
agent with a very potent analgesic and anti-inflammatory
action, acting as a possible antagonist of the of the NMDA
receptors (McCormack et al., 1994).
One of the more intriguing reactions of cells to a
severe metabolic insult is a change in their gene expression,
which has become an important focus of interest in cerebral
ischemia since several regulatory genes play an important
role in the various aspects of infarct pathophysiology
(Schneider et al., 2004). This study aimed to investigate the
pattern of expression of the protein and gene NMDAR, in
an experimental model of transient focal cerebral ischemia
without reperfusion and the hole of neuroprotection with
hypothermia and ketoprofen.
MATERIAL AND METHOD
One hundred and twenty adult male rats (Rattus
norvegicus) weighing 280-310 g were used and the animals
were randomly divided into 3 experimental groups: control
(C), 20 animals sacrificed without being submitted to the
surgical procedure; sham (S), 20 control animals submitted
to complete simulation of the surgical procedure but without
obstruction of the middle cerebral artery (MCA) and then
sacrificed, and ischemic (I), 80 animals submitted to focal
ischemia by occlusion of the MCA for 1 hour and then
sacrificed. This group was subdivided into 4 subgroups of
20 animals each: ischemic subgroup (Sg I), ischemic
subgroup submitted to hypothermia (Sg IH), ischemic
subgroup treated with ketoprofen (Sg IK), and ischemic
subgroup submitted to hypothermia and treated with
ketoprofen (Sg IHK). Ten animals from each experimental
group, for a total of 60 animals, were used for the delimitation
of the ischemic area using a morphometric method, for
controlling the efficacy and the extension of the ischemia.
The experiments were carried out according to the
Ethical Principles for Experimental Animals (COBAO) and
the study was approved by the Animal Experimentation
Committee (CETEA) of the Faculty of Medicine of Ribeirão
Preto, University of São Paulo (Protocol nº 0347/2005).
Induction of Cerebral Ischemia. All animals were partially
anesthetized by halothane inhalation and intubated with an
orotracheal cannula. At two times during the ischemic period,
arterial blood samples were collected for the determination
of glycemia, paCO2, paO2 and pH. The animals in the Sg IH
subgroup were submitted to moderate intra-ischemic
hypothermia (32-34 ºC) by anesthesia itself and by air
conditioning the room, the animals in the Sg IK subgroup
received an intravenous injection of ketoprofen at the dose
of 10 mg/kg body weight 5 minutes before the induction of
ischemia, and the animals in the Sg IHK subgroup were
submitted to intra-ischemic hypothermia and similarly
injected with ketoprofen. MCA occlusion was carried out
through the external carotid artery which was ligated
cranially and sectioned for the retrograde introduction of a
2.5 cm long obstructive 4-0 mononylon suture with one end
thickened with silicone over an extension of 5 mm (Carlotti
et al., 2001). The suture was introduced until to reach the
common carotid artery and then cranially progressed through
the internal carotid artery until to reach and to obstruct the
MCA.
Morphometric analysis of infarct volume. Infarct volumes
were measured by morphometric analysis of infarct areas
that were defined by 2,3,5-triphenyl tetrazolium (TTC). The
brains of the animals were removed and cut into coronal
sections using a rat brain matrice and were placed in a 2%
solution of the dye TTC, developed at 37 ºC for 30 minutes,
and then stored in 10% buffered formalin solution. Cross-
sectional area of the TTC-stained region for each brain slice
was determined using an image analyzer (Axion vision 4.6
– Carl Zeiss). After integration of these stained areas, the
indirect method of Swanson et al. was used to determine
infarct volume (subtraction of residual left hemisphere
cortical volume from the cortical volume of the intact right
hemisphere) (Swanson et al., 1990).
Analysis of Protein Expression by immuno-
histochemistry. The samples were embedded in paraffin and
coronal sections (3 µm) of the brain were incubated with
3% H2O2 and Pierce solution to block endogenous peroxidase
and biotin, respectively. Sections were subsequently
incubated with primary antibody against NMDA-R1 (1:200
dilution- ABBI250701 - Abbiotech®) and with biotin-
conjugated secondary anti-rabbit antibody (1:1000; Vector
Laboratories Inc., Burlingame, CA) and streptavidin-
conjugated peroxidase (Vecstatin Abc kit, Vector
Laboratories Inc.). Color was developed by the addition of
DAB (Sigma Chemical, St. Louis, MO).  To evaluate the
background reaction, procedures were also perfomed in
sections incubated only with the secondary antibodies
(indirect technique) or in the absence antibodies (direct
technique).  A field in an increase of 400x in the area where
there was greater concentration of positive cells or marked
(areas of "hot spots") was selected for the analysis of protein
expression of NMDAR1 in each layer of immuno-
histochemical reaction. The number with positive staining
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for NMDAR1 was measured by using a camera (Axio Cam,
Zeiss, Germany) and the program Axiovision 4.6 (Zeiss,
Germany).
The method used for counting NMDAR positive cells
graded from «+» to «++++» according to the intensity of
immunoreactivity. The fields chosen in the slides were
evaluated as the percentage of cells marked and graded from
0 (zero): no mark, up to 25%: 1 + (low expression), 25% to
50%: 2 + + (intermediate expression); 50% to 75%: 3 + + +
(high expression) and over 75% of cells marked: 4 + + + +
(high expression).
RNA extraction and cDNA synthesis. After removal of the
brain, the cortex of the left cerebral hemisphere was isolated
and a sample measuring 7 mm in diameter was punched out
for a biopsy centered along the MCA. The samples were
placed in cryotubes and stored in liquid nitrogen at – 196oC
until the time for RNA extraction.  For this procedure, 250
µl PBS + 750 µl TRIZOL were added to the brain tissue
samples which were then lysed in a Polytron homogenizer
for about 3 minutes. Next, total RNA was extracted by the
TRIZOL method (Invitrogen, Carlsbad, CA, USA) according
to manufacturer instructions. Complementary DNA (cDNA)
was constructed by reverse transcription using the enzyme
Superscript II and the DNA obtained was amplified by real-
time quantitative PCR (RQ-PCR).
Analysis of Gene Expression Patterns by RQ-PCR. For
the quantitative analysis of the gene under study, NMDAR
(Rn 01530859), we used the commercially available system
TaqMan Assay-on-demand, which consists of
oligonucleotides and probes (Applied Biosystems, Foster
City, CA, USA). Reverse transcription was performed using
4 µg total RNA for each sample in 40 mL of the total reaction
mixture, with the addition of oligo (dT)20 (Cat. Nº. 18418-
020, Invitrogen) and Superscript II reverse transcriptase (Cat.
Nº. 18064-022, Invitrogen), according to manufacturer
instructions. The cDNA obtained was diluted 1:10 and 2.5
µL was used for each 15 µL of the RQ-PCR mixture using
the TaqMan Master Mix (Applied Biosystems).
All reactions were carried out in duplicate and
analyzed with the 7500 Sequence Detection System
apparatus (Applied Biosystems). Data were analyzed using
the ABI-7500 SDS software. The maximum standard
deviation between duplicates was 10%. The total RNA ab-
sorbed was normalized on the basis of the Ct value for the
GAPDH gene (Rn_99999916). The variation of expression
among samples was calculated by the 2-∆∆Ct method, with
the mean delta Ct value for a group of 20 samples from con-
trol rats being used as a calibrator.
Statistical Analysis. The expression of the gene and protein
under study showed normal distribution in the various
groups. Data concerning the mean gene and protein
expression in the various groups were analyzed statistically
by one-way ANOVA followed by the Bonferroni post-test
using the GraphPad Prism software, version 4.00 for
Windows, (GraphPad Software, San Diego, CA, USA). The
level of significance was set at p < 0.05 for two-tailed tests.
RESULTS
Morphometric analysis showed that the infarct area
corresponding to the territory of irrigation of the MCA was
clearly observed in the animals of the ischemic group (Fig. 1).
The analysis of the percentage of the volume of
ischemic area in relation to the normal hemisphere among the
animals of the ischemic group with neuroprotection (SgIH,
SgIK and SgIHK) revealed a smaller area of infarction in
relation to animals of the isquemic subgroup (SgI) (p<0.0001,
one-way ANOVA, p = 0001, Bonferroni post-test (Fig. 1), and
similar areas to that observed in animals of the control group.
Analysis of protein expression of NMDAR1 by
immunohistochemistry (figure 3) showed that it was
intermediate (++) for all animals in the group SgI, with high
intensity (+++) only in animal 10 and with average percentage
of positive cells of 44.02%; that  in the group SgIK it was
intermediate (+ +) for all animals, with high intensity (+++)
only in animal 5 and the average percentage of positive cells
of 38.23%; and that in the groups SgIH and SgIHK it was
intermediate (++) in all animals and with average percentage
of positive cells of 26.12% and 26.93, respectively.
Fig. 1. Photomicrography of the expression of NMDAR1 antibody
in the SgIH subgroup. Positive cells in the nervous tissue to the
antibody (*); (400x).
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Figure 2 shows  mean and standard deviation of the percentage of positive cells to
NMDAR1 antibody in the ischemic group. There was a statistically significant difference
(p = 0.0005 one-way ANOVA) between the subgroups SgIxSgIH (p <0.001), SgIxSgIK (p
<0.05) and SgIxSgIHK (p <0.01), Bonferroni post test.
DISCUSSION
The model of
ischemia induction by
occlusion of the MCA with an
obstructive suture has been
used by several investigators
and has been shown to produ-
ce consistent and reproducible
focal injuries (Dias et al.;
Carlotti et al.). In our study,
morphological measure of the
infarct volume was randomly
performed in 10 animals of
each experimental group for
controlling the occurrence of
ischemia and confirmed the
data of the literature.
S e v e r a l
morphometric changes are
detected in the affected ce-
rebral area after experimen-
tal cerebral ischemia,
including neuronal and glial
cell death by necrosis and
apoptosis (Thorburn, 2004;
Matsumori et al., 2005;
Siegelin et al., 2005; Zhang
et al., 2006). 
After minutes of a
focal ischemic stroke
occurring, the core of brain
tissue exposed to the most
dramatic blood flow
reduction is fatally injured
and subsequently undergoes
necrotic cell death that is
surrounded by a zone of less
severely affected tissue but
metabolically active known
as “ischemic penumbra” and
represents the region in which
there is opportunity for
salvage via poststroke therapy
(Broughton et al., 2009).
The rapid depletion
of energy after cerebral
ischemia leads to a loss of
membrane potential and
Figure 3 illustrates the mean expression of the NMDA gene in the experimental groups.
The expression in animals of the ischemic group was higher when compared with control
and sham (p = 0.0001, one-way ANOVA, p < 0.05, Bonferroni post-test), and it was lower
in the animals of the treated ischemic subgroups (SgIH, SgIK and SgIHK) compared to
control, sham and ischemic (SgI) animals (p = 0.0001, one-way ANOVA, p < 0.01, Bonferroni
post-test).
Fig. 2. Mean and standard deviation of the percentage of positive cells to NMDAR1 antibody in the
ischemic group.
Fig. 3. Expression of the NMDAR1 gene in the groups studied. Data are reported as means ± SD. The
deviation bars indicate a 95% confidence interval.
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depolarization of nerves. Voltage-dependent Ca2 channels are
activated, and excitatory amino acids are released into the
extracellular space (Mergenthaler et al., 2004). A cytotoxic
accumulation of intracellular Ca2 subsequently occurs and is
thought to initiate a series of cytoplasmic and nuclear events,
including the apoptosis by intrinsic pathway (Dirnagl et al.,
1999). The most studied ion channels in ischemic stroke are
the group of receptor-operated cation channels opened by
glutamate, which accumulates in the extracellular space during
cerebral. Binding of glutamate to ionotropic NMDA and
AMPA (amino-3-hydroxy-5-methyl-4-isoxazolepropionic
acid) receptors promotes a further increase in Ca2 entry
ischemia (Mergenthaler et al.; Simard et al., 2007).
It is well established that NMDAR is involved in the
brain injury associated with acute ischemic stroke. Many
studies have shown that stimulation of the neurotransmitters
NMDA-type, leads to cell death in cerebral ischemia
(Siciliano et al., 1996; Kumari & Ticku, 2000; Zheng et al.,
2008). It was reported that cerebral ischemia could change
the expression of NMDAR subunits in the gerbil and rat
brain in vivo (Kang et al., 2001; Won et al., 2001; Friedman
et al., 2001). We also observed an increase in the protein
and gene expression of NMDA after temporary focal cere-
bral ischemia in rats. This neuroexcitotoxicity observed plays
an important role in apoptosis by intrinsic pathways
culminating in cell death (Broughton et al.).
 The large amount of glutamate accumulated in the
extracellular space in the ischemic brain is probably due
to glutamate release and impairment of its uptake (Rossi
et al., 2000), with this high level of glutamate being thought
to induce the hyperactivation of NMDARs followed by
excess Ca2+ influx into neurons, and cell death (Silva et
al., 2007).
Dias et al. observed histopathological differences
among rats submitted to focal cerebral ischemia previously
treated with ketoprofen, an antagonist of the NMDA recep-
tor.  A protective effect was also observed in the hippocampus
of gerbils after a 5 minute ischemia followed by reperfusion
for 21 days.  Silva et al. evaluated a 48 hours period of
ischemia in rats using histopathological and biochemical
analyses and did not observe protective effect of ketoprofen.
In the present study we observed an increase in the protein
and gene expression of NMDAR1 after temporary focal ce-
rebral ischemia and a decrease of this neurotransmitter in
animals that had some kind of neuroprotection (hypothermia,
ketoprofen or both), indicating a decrease in the stimulation
caused by the ischemic insult.
After one hour focal cerebral ischemia in rats,
NMDAR1 was highly expressed, suggesting greater NMDA
receptor neurotoxicity and that the neuroprotective effect of
both, hypothermia and ketoprofen is directly involved with
the NMDA.
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RESUMEN: NMDAR (N-metil-D-aspartato) es un tipo de receptor de glutamato ionotrópico y está  ampliamente distribuido en
el sistema nervioso  central (SNC). En el SNC de mamíferos, NMDAR se destaca de manera importante en el proceso fisiopatológico de
la isquemia cerebral. Este estudio tuvo como objetivo investigar el patrón de expresión de proteínas y genes para el  NMDA neurotransmisor
excitatorio experimental de la isquemia cerebral focal y el vacío en la neuroprotección con hipotermia y ketoprofeno.  Se dividieron 120
ratas aleatoriamente en grupos de 6 animales cada uno (20): Control - sin cirugía; Sham - simulación de  cirugía; isquémicas - isquemia
focal durante 1 hora, sin  reperfusión isquémica; hipotermia intra-isquémica; isquemia; previa aplicación de ketoprofeno intravenoso, e
hipotermia isquémica y ketoprofeno. Diez animales de cada grupo experimental fueron utilizados para establecer el volumen de infarto. La
isquemia cerebral focal transitoria fue obtenida en ratas mediante oclusión de la arteria cerebral media con una sutura intraluminal. El
volumen de infarto fue medido mediante análisis morfométrico de las áreas de infarto definidas por cloruro de trifenil tetrazolio y
patrones de expresión de la proteína y el gen de NMDA, fueron evaluados por inmunohistoquímica y PCR cuantitativa en tiempo real,
respectivamente. Se observaron aumentos en la proteína y en el gen del receptor de NMDA en las áreas isquémicas y estos aumentos
fueron reducidos por la hipotermia y ketoprofeno. El aumento de la proteína del receptor de NMDA y la expresión génica observada en
los animales isquémicos fue reducido mediante hipotermia y ketoprofeno. Los aumentos del receptor de NMDA en el área isquémica
sugiere que la neuro excitotoxicidad mediada por NMDA desempeña un papel importante en la muerte celular y que el efecto neuroprotector
de ambos, hipotermia y ketoprofeno está directamente relacionado al  NMDA.
PALABRAS CLAVE: Expresión de NMDA; Isquemia cerebral; Neuroprotección (hipotermia y ketoprofeno).
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